Cargando…
Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines
BACKGROUND: Medical observation period is a period of 14 days after any exposure to coronavirus disease 2019 (COVID-19) occurred. This review aimed to summarize and analyze the herbs and herbal formulae recommended by available guidelines. METHODS: A total of 14 sources were searched for potential g...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328533/ https://www.ncbi.nlm.nih.gov/pubmed/32691000 http://dx.doi.org/10.1016/j.imr.2020.100465 |
_version_ | 1783552740937433088 |
---|---|
author | Ang, Lin Lee, Hye Won Kim, Anna Lee, Myeong Soo |
author_facet | Ang, Lin Lee, Hye Won Kim, Anna Lee, Myeong Soo |
author_sort | Ang, Lin |
collection | PubMed |
description | BACKGROUND: Medical observation period is a period of 14 days after any exposure to coronavirus disease 2019 (COVID-19) occurred. This review aimed to summarize and analyze the herbs and herbal formulae recommended by available guidelines. METHODS: A total of 14 sources were searched for potential guidelines that provide herbal medicine treatment for the medical observation period of COVID-19. We summarized and analyzed the recommended herbal formulae and performed a network analysis to identify the relationship between herbs. RESULTS: We found 9 guidelines that provide herbal formula for medical observation based on clinical manifestation. There are 12 herbal formulae with a total of 53 herbs recommended by the guidelines. The result of our network analysis showed that the herb Citri Reticulatae Pericarpium (Chen Pi) strongly paired with the herb Glycyrrhizae Radix et Rhizoma (Gan Cao). CONCLUSION: This review briefly summarized the usage of herbal medicine for the medical observation period of COVID-19 and may serve as a reference for future studies. More research is needed in the future to provide evidence on the usage of herbal medicine in various phases of COVID-10. |
format | Online Article Text |
id | pubmed-7328533 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-73285332020-07-01 Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines Ang, Lin Lee, Hye Won Kim, Anna Lee, Myeong Soo Integr Med Res Review Article BACKGROUND: Medical observation period is a period of 14 days after any exposure to coronavirus disease 2019 (COVID-19) occurred. This review aimed to summarize and analyze the herbs and herbal formulae recommended by available guidelines. METHODS: A total of 14 sources were searched for potential guidelines that provide herbal medicine treatment for the medical observation period of COVID-19. We summarized and analyzed the recommended herbal formulae and performed a network analysis to identify the relationship between herbs. RESULTS: We found 9 guidelines that provide herbal formula for medical observation based on clinical manifestation. There are 12 herbal formulae with a total of 53 herbs recommended by the guidelines. The result of our network analysis showed that the herb Citri Reticulatae Pericarpium (Chen Pi) strongly paired with the herb Glycyrrhizae Radix et Rhizoma (Gan Cao). CONCLUSION: This review briefly summarized the usage of herbal medicine for the medical observation period of COVID-19 and may serve as a reference for future studies. More research is needed in the future to provide evidence on the usage of herbal medicine in various phases of COVID-10. Elsevier 2020-09 2020-07-01 /pmc/articles/PMC7328533/ /pubmed/32691000 http://dx.doi.org/10.1016/j.imr.2020.100465 Text en © 2020 Korea Institute of Oriental Medicine. Publishing services by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Article Ang, Lin Lee, Hye Won Kim, Anna Lee, Myeong Soo Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines |
title | Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines |
title_full | Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines |
title_fullStr | Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines |
title_full_unstemmed | Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines |
title_short | Herbal medicine for the management of COVID-19 during the medical observation period: A review of guidelines |
title_sort | herbal medicine for the management of covid-19 during the medical observation period: a review of guidelines |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328533/ https://www.ncbi.nlm.nih.gov/pubmed/32691000 http://dx.doi.org/10.1016/j.imr.2020.100465 |
work_keys_str_mv | AT anglin herbalmedicineforthemanagementofcovid19duringthemedicalobservationperiodareviewofguidelines AT leehyewon herbalmedicineforthemanagementofcovid19duringthemedicalobservationperiodareviewofguidelines AT kimanna herbalmedicineforthemanagementofcovid19duringthemedicalobservationperiodareviewofguidelines AT leemyeongsoo herbalmedicineforthemanagementofcovid19duringthemedicalobservationperiodareviewofguidelines |